EscrimHEMA: Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology Patients

Sponsor
University Hospital, Angers (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06026046
Collaborator
(none)
80
2
1
28.1
40
1.4

Study Details

Study Description

Brief Summary

In 20 years, the prognosis of hematology patients has improved thanks to the development and adaptation of treatments and better risk management. However, medium and long-term complications of intensive treatments are common and remain a real public health problem. Indeed, intensive treatments associated with room confinement within a protected unit expose patients to physical deconditioning of multifactorial pathophysiological mechanisms. If this deconditioning is neglected, response to treatment, tolerance, quality of life and, in the longer term, survival will be impacted.

Several teams have demonstrated the feasibility and the benefits of physical support for patients with prolonged aplasia. These studies focused on peripheral stem cell allograft, which occur late in the treatment of acute leukemia. On the other hand, studies evaluating the benefits of physical support as soon as the diagnosis of acute leukemia is made and intensive treatments are started are rare. Implementing a adapted sport program from the diagnostic and throughout the course of treatment is therefore a worthwhile subject for research.

The adapted sport chosen was fencing because it responds to hematological problems. Fencing is adaptable without carrying or receiving blow, can be practiced standing up, in an armchair or in bed, involves praxis and concentration, and involves the whole body. It can be practiced individually or as part of a team, in a protected room or in a unit corridor. Fencing is a fighting sport and includes a psychological aspect, with a possible projection of a fight against the disease. In addition, fencing is carried out by a non-medical or paramedical practitioner, which can reinforce or recreate an image of normal activity. Finally, the attention required by listening to the fencing master and the necessary concentration unconsciously pushes the patient to "get out of his illness".

The aim of this pilot study is to assess the feasibility, throughout the care pathway, of an adapted sport program based on fencing in adult patients with hematological malignancies receiving intensive treatment, to reduce physical deconditioning.

Condition or Disease Intervention/Treatment Phase
  • Other: Adapted sport program based on fencing
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology Patients Receiving Intensive Treatment
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Feb 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patients benefiting from the adapted sport program based on fencing

Other: Adapted sport program based on fencing
This adapted sport program includes 3 to 5 sessions per week of adapted fencing (excluding weekends and public holidays), carried out either by a fencing master trained in adapted sport, or by an APA teacher trained in adapted fencing by the fencing master. Sessions can last from 10 to 30 minutes. The course of the session is validated by the fencing master and adapted to each patient. The limiting factors are taken into account, in order to direct towards a specific practice. The sessions are progressive with very short and varied sequences calling on the imagination and experience of the fencing masters.

Outcome Measures

Primary Outcome Measures

  1. Proportion of patients attending at least 50% of the schedulded lessons over the entire duration of the program [1 year]

    The proportion of patients attending at least 50% of the scheduled fencing lessons over the entire duration of the program will be used to evaluate the feasibility of the adapted sport program based on fencing.

Secondary Outcome Measures

  1. Number of actual fencing lessons compared to number of scheduled fencing lessons [1 year]

    The comparison between the number of fencing lessons patients actually attended and the number of fencing lessons theoretically planned will be used to assess adherence to the adapted sport program.

  2. Average duration of fencing lessons [1 year]

    The average duration of the program corresponds to the average duration of the adapted sport program for each participant in real-life conditions. It will be used to assess the adequacy of the theoretical modalities and the implementation of the program in real-life conditions .

  3. Average duration of the program [1 year]

    The average duration of the program corresponds to the average duration of the adapted sport program for each participant in real-life conditions. It will be used to assess the adequacy of the theoretical modalities and the implementation of the program in real-life conditions .

  4. Typology of patients attending at least 50% of the scheduled fencing lessons over the entire duration of the program [1 year]

    The typology of patients will be described according to pathology, age, co-morbidities, type of intensive chemotherapy, treatment phase (induction, consolidation, allograft, CAR-T cells)

  5. Comparison between the EORTC QLQC30 score obtained at inclusion and the score obtained at each prolonged hospitalization discharge and at 3 months, 6 months and 12 months [1 year]

    The EORTC QLQC30 is used to assess the quality of life of cancer patients

  6. Evolution of the distance covered in 6-minute walk test between inclusion and 6-month follow-up [6 months]

    The 6-minute walk test is used to assess functional exercise capacity of an individual. It measures the distance an individual is able to walk over a 6-minute period.

  7. Evolution of the SPPB (Short Physical Performance Battery) score between inclusion and 6-month follow-up [6 months]

    The SPPB test is used to assess the physical performance of an individual. Il is the result of the scores of three criteria: the balance test, the walking speed test and the sit-to-stand test. The sum of the scores of all the tests gives an overall performance score.

  8. Evolution of the upper limb grip strength measured by dynamometer between inclusion and 6-month follow-up [6 months]

    This test is used to measure muscle strength in the hand and forearm.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patient admitted to a protected unit of the Hematology department of one of the participating centers

  • Patient with acute leukemia treated in induction with "3+7" or "5+7" intensive treatment or by an equivalent treatment (Vyxeos, azacitidine+vĂ©netoclax), or patient admitted for an allograft or CAR-T cells and not included at the diagnosis of the disease

  • Patient eligible for intensive chemotherapy

  • Patient requiring prolonged hospitalization with room confinement

  • Signed informed consent form

Exclusion Criteria:
  • Patient with a neurological or cardiac disease that contraindicates the practice of fencing

  • No intensive treatment with prolonged hospitalization

  • Pregnant, parturient or breastfeeding woman

  • Person deprived of liberty by judicial or administrative decision

  • Person under forced psychiatric care

  • Person under legal protection

  • Person unable to express consent

  • Person not covered by or not benefiting from a social security system

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital, Angers Angers France 49000
2 University Brest Hopspital Brest France 29609

Sponsors and Collaborators

  • University Hospital, Angers

Investigators

  • Principal Investigator: Aline MD Schmidt, PHD, University Hospital, Angers

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Angers
ClinicalTrials.gov Identifier:
NCT06026046
Other Study ID Numbers:
  • 49RC23_0088
  • 2023-A01596-39
First Posted:
Sep 6, 2023
Last Update Posted:
Sep 6, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 6, 2023